Suppressing the intestinal farnesoid X receptor/sphingomyelin phosphodiesterase 3 axis decreases atherosclerosis.

MLA

Qing Wu, et al. “Suppressing the Intestinal Farnesoid X Receptor/Sphingomyelin Phosphodiesterase 3 Axis Decreases Atherosclerosis.” Journal of Clinical Investigation, vol. 131, no. 9, May 2021, pp. 1–16. EBSCOhost, https://doi.org/10.1172/JCI142865.

APA

Qing Wu, Lulu Sun, Xiaomin Hu, Xuemei Wang, Feng Xu, Bo Chen, Xianyi Liang, Jialin Xia, Pengcheng Wang, Daisuke Aibara, Shaofei Zhang, Guangyi Zeng, Chuyu Yun, Yu Yan, Yicheng Zhu, Bustin, M., Shuyang Zhang, Gonzalez, F. J., Changtao Jiang, & Wu, Q. (2021). Suppressing the intestinal farnesoid X receptor/sphingomyelin phosphodiesterase 3 axis decreases atherosclerosis. Journal of Clinical Investigation, 131(9), 1–16. https://doi.org/10.1172/JCI142865

Chicago

Qing Wu, Lulu Sun, Xiaomin Hu, Xuemei Wang, Feng Xu, Bo Chen, Xianyi Liang, et al. 2021. “Suppressing the Intestinal Farnesoid X Receptor/Sphingomyelin Phosphodiesterase 3 Axis Decreases Atherosclerosis.” Journal of Clinical Investigation 131 (9): 1–16. doi:10.1172/JCI142865.